Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 3
1969 4
1970 1
1971 4
1972 2
1973 3
1975 1
1976 1
1977 1
1978 1
1979 1
1980 3
1981 1
1982 1
1983 3
1985 2
1986 1
1987 2
1988 6
1990 2
1991 4
1992 7
1993 2
1994 12
1995 5
1996 11
1997 9
1998 11
1999 14
2000 12
2001 20
2002 19
2003 19
2004 15
2005 23
2006 32
2007 28
2008 34
2009 24
2010 29
2011 29
2012 37
2013 37
2014 32
2015 26
2016 42
2017 30
2018 43
2019 48
2020 46
2021 65
2022 63
2023 46
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

858 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, Berry C, López-Sendón J, Ostadal P, Koenig W, Angoulvant D, Grégoire JC, Lavoie MA, Dubé MP, Rhainds D, Provencher M, Blondeau L, Orfanos A, L'Allier PL, Guertin MC, Roubille F. Tardif JC, et al. Among authors: dube mp. N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16. N Engl J Med. 2019. PMID: 31733140 Free article. Clinical Trial.
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
Bouabdallaoui N, Tardif JC, Waters DD, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Lopez-Sendon J, Gamra H, Kiwan GS, Blondeau L, Orfanos A, Ibrahim R, Grégoire JC, Dubé MP, Samuel M, Morel O, Lim P, Bertrand OF, Kouz S, Guertin MC, L'Allier PL, Roubille F. Bouabdallaoui N, et al. Among authors: dube mp. Eur Heart J. 2020 Nov 7;41(42):4092-4099. doi: 10.1093/eurheartj/ehaa659. Eur Heart J. 2020. PMID: 32860034 Free PMC article. Clinical Trial.
Considerations for psychological safety with system-focused debriefings.
Dube M, Kessler D, Huang L, Petrosoniak A, Bajaj K. Dube M, et al. BMJ Simul Technol Enhanc Learn. 2020 Jan 15;6(3):132-134. doi: 10.1136/bmjstel-2019-000579. eCollection 2020. BMJ Simul Technol Enhanc Learn. 2020. PMID: 35518380 Free PMC article. No abstract available.
Pharmacogenomics of blood lipid regulation.
Legault MA, Tardif JC, Dubé MP. Legault MA, et al. Among authors: dube mp. Pharmacogenomics. 2018 May;19(7):651-665. doi: 10.2217/pgs-2018-0007. Epub 2018 Apr 30. Pharmacogenomics. 2018. PMID: 29706123 Review.
The time to offer treatments for COVID-19.
Ngo BT, Marik P, Kory P, Shapiro L, Thomadsen R, Iglesias J, Ditmore S, Rendell M, Varon J, Dubé M, Nanda N, In G, Arkfeld D, Chaudhary P, Campese VM, Hanna DL, Sawcer DE, Ehresmann G, Peng D, Smogorewski M, Armstrong A, Dasgupta R, Sattler F, Brennan-Rieder D, Mussini C, Mitja O, Soriano V, Peschanski N, Hayem G, Confalonieri M, Piccirillo MC, Lobo-Ferreira A, Bello Rivero I, Turkia M, Vinjevoll EH, Griffin D, Hung IF. Ngo BT, et al. Among authors: dube m. Expert Opin Investig Drugs. 2021 May;30(5):505-518. doi: 10.1080/13543784.2021.1901883. Epub 2021 Apr 23. Expert Opin Investig Drugs. 2021. PMID: 33721548 Free PMC article. Review.
Lipoprotein (a), arterial inflammation, and PCSK9 inhibition.
Tardif JC, Rhéaume E, Rhainds D, Dubé MP. Tardif JC, et al. Among authors: dube mp. Eur Heart J. 2019 Sep 1;40(33):2782-2784. doi: 10.1093/eurheartj/ehz087. Eur Heart J. 2019. PMID: 30838412 No abstract available.
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality.
Schunk SJ, Kleber ME, März W, Pang S, Zewinger S, Triem S, Ege P, Reichert MC, Krawczyk M, Weber SN, Jaumann I, Schmit D, Sarakpi T, Wagenpfeil S, Kramann R, Boerwinkle E, Ballantyne CM, Grove ML, Tragante V, Pilbrow AP, Richards AM, Cameron VA, Doughty RN, Dubé MP, Tardif JC, Feroz-Zada Y, Sun M, Liu C, Ko YA, Quyyumi AA, Hartiala JA, Tang WHW, Hazen SL, Allayee H, McDonough CW, Gong Y, Cooper-DeHoff RM, Johnson JA, Scholz M, Teren A, Burkhardt R, Martinsson A, Smith JG, Wallentin L, James SK, Eriksson N, White H, Held C, Waterworth D, Trompet S, Jukema JW, Ford I, Stott DJ, Sattar N, Cresci S, Spertus JA, Campbell H, Tierling S, Walter J, Ampofo E, Niemeyer BA, Lipp P, Schunkert H, Böhm M, Koenig W, Fliser D, Laufs U, Speer T; eQTLGen consortium; BIOS consortium. Schunk SJ, et al. Among authors: dube mp. Eur Heart J. 2021 May 7;42(18):1742-1756. doi: 10.1093/eurheartj/ehab107. Eur Heart J. 2021. PMID: 33748830 Free PMC article.
858 results